Comparative analysis of hematological changes in patients with rheumatoid arthritis treated with different Janus kinase inhibitors: a real-world study.

Conversely, the platelet count exhibited an increasing trend in patients treated with baricitinib compared with that in patients treated with tofacitinib (Pillai’s trace value 0.063, p<0.001) or upadacitinib (Pillai’s trace value 0.029, p<0.001).

also in 63,971 other papers

ANC values showed a decreasing trend across all three groups from baseline to 6 months; however, no significant difference in the rate of reduction was observed among the three groups (Pillai’s trace value 0.006, p=0.753).

also in 47,180 other papers